Stockscreener 앱 받기
1.38
21.05%
0.24
전일 마감가:
$1.14
열려 있는:
$1.1705
하루 거래량:
232.09K
Relative Volume:
2.93
시가총액:
$4.53M
수익:
$832.80K
순이익/손실:
$-21.55M
주가수익비율:
-0.1146
EPS:
-12.0465
순현금흐름:
$-12.71M
1주 성능:
+13.11%
1개월 성능:
-22.47%
6개월 성능:
-71.19%
1년 성능:
-90.37%
1일 변동 폭
$1.1705
$1.39
1주일 범위
$1.10
$1.39
52주 변동 폭
$0.9532
$41.20
Hcw Biologics Inc Stock (HCWB) Company Profile
명칭
Hcw Biologics Inc
전화
954-842-2024
주소
2929 N COMMERCE PKWY, MIRAMAR
HCWB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
1.38 | 3.74M | 832.80K | -21.55M | -12.71M | -12.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Hcw Biologics Inc 주식(HCWB)의 최신 뉴스
US Stocks Recap: Is HCW Biologics Inc. forming a breakout patternJuly 2025 Highlights & Verified Momentum Watchlists - baoquankhu1.vn
Is HCW Biologics Inc. stock recession proofEarnings Recap Summary & Weekly Sector Rotation Insights - Улправда
How analysts rate HCW Biologics Inc. stock todayQuarterly Trade Summary & AI Enhanced Execution Alerts - ulpravda.ru
Will HCW Biologics Inc. stock attract ESG investorsJuly 2025 Spike Watch & Safe Capital Preservation Plans - Улправда
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions - Investing.com Nigeria
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions By Investing.com - Investing.com South Africa
HCW Biologics Restructures Obligations to Regain Nasdaq Compliance - TipRanks
HCW Biologics Achieves Nasdaq Compliance Milestone - TradingView — Track All Markets
Returns Recap: Will HCW Biologics Inc stock attract ESG investorsEarnings Beat & Daily Price Action Insights - moha.gov.vn
HCW Biologics Granted Nasdaq Compliance Extension - MSN
Aug Analyst Calls: Is HCW Biologics Inc stock recession proofGDP Growth & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
US Market Recap: How analysts rate HCW Biologics Inc stock todayWeekly Investment Summary & Precise Buy Zone Identification - Bộ Nội Vụ
HCW Biologics (NASDAQ:HCWB) Shares Down 0.2% – Time to Sell? - Defense World
Reviewing HCW Biologics (NASDAQ:HCWB) and ImmunityBio (NASDAQ:IBRX) - Defense World
HCW Biologics Earnings Notes - Trefis
Is HCW Biologics Inc. stock gaining market shareJuly 2025 Opening Moves & Verified Momentum Stock Ideas - Улправда
Is HCW Biologics Inc. stock attractive for growth ETFsMarket Performance Report & Low Drawdown Investment Ideas - Улправда
Is HCW Biologics Inc. stock a buy in volatile markets2025 Price Targets & Long Hold Capital Preservation Plans - Улправда
Can HCW Biologics Inc. stock deliver consistent earnings growthMarket Activity Summary & AI Forecasted Entry/Exit Points - DonanımHaber
Can HCW Biologics Inc. stock deliver strong Q4 earningsMarket Activity Report & Community Trade Idea Sharing - bolumsonucanavari.com
HCW Biologics Inc Stock Analysis and ForecastREITs Market Trends & Investment Timing Techniques - earlytimes.in
Will HCW Biologics Inc. stock benefit from sector rotationJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Is HCW Biologics Inc. overvalued or undervalued? - Markets Mojo
HCW Biologics Amends License Agreement with Trimmune - MSN
How HCW Biologics Inc. stock performs in rate cut cyclesQuarterly Earnings Report & Real-Time Volume Analysis - Newser
HCW Biologics (NASDAQ:HCWB) Trading Down 7.1% – Here’s What Happened - Defense World
HCW Biologics (HCWB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Hedge Fund Bets: Why HCW Biologics Inc. stock is seen as undervaluedPortfolio Growth Summary & Weekly Chart Analysis and Guides - moha.gov.vn
Form 8-KCurrent report - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results - ADVFN
HCW Biologics Inc. (HCWB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HCW Biologics Secures $4M Through Warrant Exercise - MSN
Why HCW Biologics Inc. stock attracts high net worth investorsMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Is HCW Biologics Inc. stock positioned well for digital economyMarket Movers & Safe Entry Trade Reports - newser.com
Will HCW Biologics Inc. stock benefit from infrastructure spending2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
HCW Biologics Begins Phase 1 Trial for HCW9302 - MSN
[8-K] HCW Biologics Inc. Reports Material Event | HCWB SEC FilingForm 8-K - Stock Titan
Insiders' US$3.05m Investments In Red Following HCW Biologics' US$1.1m Dip In Market Value - simplywall.st
What analysts say about HCW Biologics Inc stockSector Rotation Strategies & Low Risk Trading Growth - earlytimes.in
Why retail investors favor HCW Biologics Inc. stockShort Setup & Daily Oversold Stock Bounce Ideas - newser.com
HCW Biologics secures $4 million through warrant exercise agreement By Investing.com - Investing.com Nigeria
HCW Biologics enters amended licensing agreement with Beijing Trimmune Biotech - Investing.com Nigeria
Using fundamentals and technicals on HCW Biologics Inc.Market Performance Recap & Real-Time Volume Surge Alerts - newser.com
Hcw Biologics Inc (HCWB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Hcw Biologics Inc 주식 (HCWB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Winer Gary M | Director |
May 16 '25 |
Buy |
7.45 |
1,342 |
9,998 |
4,075 |
| GARRETT SCOTT T | Director |
May 16 '25 |
Buy |
7.45 |
13,423 |
100,001 |
25,505 |
| Winer Gary M | Director |
May 08 '25 |
Buy |
26.00 |
2,308 |
60,008 |
2,733 |
| Wong Hing C | Chief Executive Officer |
May 08 '25 |
Buy |
26.00 |
92,500 |
2,405,000 |
493,857 |
| GARRETT SCOTT T | Director |
May 08 '25 |
Buy |
26.00 |
5,385 |
140,010 |
12,082 |
| Byam Rebecca | Chief Financial Officer |
May 08 '25 |
Buy |
26.00 |
8,462 |
220,012 |
43,010 |
| Flowers Lee | SVP of Business Development |
May 08 '25 |
Buy |
26.00 |
962 |
25,012 |
5,720 |
| Greene Rick S. | Director |
May 08 '25 |
Buy |
26.00 |
962 |
25,012 |
2,066 |
4.73%
0.92%
자본화:
|
볼륨(24시간):